Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA)Claude Preudhomme, Hervé Dombret, C. Sagot et al.|Blood|2002Cited by 503
Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studiesReuben Benjamin, Jackie Chappell, Farzin Farzaneh et al.|The Lancet|2020Cited by 358
Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemiaÉric Jourdan, Hervé Dombret, Nicolas Boissel et al.|Blood|2013Cited by 357
Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML)Nicolas Boissel, Claude Preudhomme, Harmony Leroy et al.|Leukemia|2006Cited by 355
Cooperating gene mutations in acute myeloid leukemia: a review of the literatureAline Renneville, Claude Preudhomme, Christophe Roumier et al.|Leukemia|2008Cited by 348